The diagnosis and management of hyperlipidemia.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002784:Cholesterol / Q000378:metabolism; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002914:Chylomicrons / Q000378:metabolism; D002994:Clofibrate / Q000627:therapeutic use; D003084:Colestipol / Q000627:therapeutic use; D003327:Coronary Disease / Q000209:etiology; D003918:Dextrothyroxine / Q000627:therapeutic use; D004041:Dietary Fats / Q000008:administration & dosage; D015248:Gemfibrozil; D006801:Humans; D006950:Hyperlipidemia, Familial Combined / Q000175:diagnosis / Q000209:etiology / Q000235:genetics; D006949:Hyperlipidemias / Q000150:complications / Q000175:diagnosis / Q000178:diet therapy / Q000601:surgery / Q000628:therapy; D008072:Hyperlipoproteinemia Type I / Q000175:diagnosis / Q000235:genetics; D006938:Hyperlipoproteinemia Type II / Q000175:diagnosis / Q000209:etiology / Q000235:genetics; D006952:Hyperlipoproteinemia Type III / Q000175:diagnosis / Q000235:genetics; D006953:Hyperlipoproteinemia Type IV / Q000175:diagnosis / Q000209:etiology / Q000235:genetics; D006954:Hyperlipoproteinemia Type V / Q000175:diagnosis / Q000209:etiology / Q000235:genetics; D008074:Lipoproteins / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism; D009355:Neomycin / Q000627:therapeutic use; D009525:Niacin / Q000627:therapeutic use; D010421:Pentanoic Acids / Q000627:therapeutic use; D011341:Probucol / Q000627:therapeutic use; D011973:Receptors, LDL / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism
D002914:Chylomicrons; D004041:Dietary Fats; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D010421:Pentanoic Acids; D011973:Receptors, LDL; D014280:Triglycerides; D002792:Cholestyramine Resin; D009525:Niacin; D003918:Dextrothyroxine; D002784:Cholesterol; D002994:Clofibrate; D009355:Neomycin; D003084:Colestipol; D011341:Probucol; D015248:Gemfibrozil